SCHEMBL21744413

SCHEMBL21744413

c1cc2c(c(N3CC(N4CCOCC4)C3)c1)CCNC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 3/20 0.44
TLR7 Q9NYK1 3/20 0.44
CD44 P16070 2/20 0.41
PIK3CD O00329 1/20 0.38
PIK3C2B O00750 1/20 0.38
MTOR P42345 1/20 0.38
HTR2C P28335 9/20 0.37
HTR2A P28223 4/20 0.35
HTR2B P41595 2/20 0.35
TLR8 Q9NR97 2/20 0.35
PRKDC P78527 2/20 0.34
PNMT P11086 1/20 0.34
MAOB P27338 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1011153 0.85 CD44 (0.49) TLR9TLR7CD44PIK3CDPIK3C2B
SCHEMBL21743788 0.84 TLR9 (0.38) TLR9TLR7CD44PIK3CDPIK3C2B
SCHEMBL21743758 0.81 CXCR4 (0.46) TLR9TLR7CD44HTR2CHTR2B
SCHEMBL21743762 0.79 CD44 (0.45) TLR9TLR7CD44HTR2CCYP3A4
SCHEMBL21744610 0.79 CD44 (0.45) TLR9TLR7CD44PIK3CDPIK3C2B
SCHEMBL21744701 0.79 CXCR4 (0.48) TLR9TLR7CD44HTR2CHTR2B
SCHEMBL21743767 0.79 CXCR4 (0.48) TLR9TLR7CD44HTR2CHTR2B
SCHEMBL21743785 0.77 CD44 (0.53) TLR9TLR7CD44HTR2CHTR2A
SCHEMBL21744163 0.76 CD44 (0.45) TLR9TLR7CD44HTR2CHTR2A
SCHEMBL21744420 0.76 CD44 (0.47) TLR9TLR7CD44HTR2CHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 TLR9 138/4885TLR7 135/4885CD44 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.